Your browser doesn't support javascript.
loading
Tumor-Associated CD163+ M2 Macrophage Infiltration is Highly Associated with PD-L1 Expression in Cervical Cancer.
Guo, Fan; Feng, Yang-Chun; Zhao, Gang; Zhang, Ran; Cheng, Zhen-Zhen; Kong, Wei-Na; Wu, Hui-Li; Xu, Bin; Lv, Xiang; Ma, Xiu-Min.
Afiliação
  • Guo F; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, People's Republic of China.
  • Feng YC; The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, People's Republic of China.
  • Zhao G; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, People's Republic of China.
  • Zhang R; The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, People's Republic of China.
  • Cheng ZZ; Department of Blood Transfusion, Affiliated Traditional Chinese Medicine Hospital of Xinjiang Medical University, Urumqi 830000, People's Republic of China.
  • Kong WN; Clinical Pathology Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830000, People's Republic of China.
  • Wu HL; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, People's Republic of China.
  • Xu B; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, People's Republic of China.
  • Lv X; The First Affiliated Hospital of Xinjiang Medical University, Urumqi 830054, People's Republic of China.
  • Ma XM; State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, Clinical Laboratory Center, Tumor Hospital Affiliated to Xinjiang Medical University, Urumqi 830011, People's Republic of China.
Cancer Manag Res ; 12: 5831-5843, 2020.
Article em En | MEDLINE | ID: mdl-32765086

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2020 Tipo de documento: Article